Morgan Stanley (MS) 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

Morgan Stanley 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-12
4:18 pm
Sale
2021-09-3013GAPREA THERAPEUTICS INC
APRE
Morgan Stanley
MS
9,248
0.900%
-44,373decrease
(-82.75%)
Filing